2784 — Alfresa Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapContrarian

Annual cashflow statement for Alfresa Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	48,180	38,591	43,795	39,359	62,007
Depreciation
Amortisation
Non-Cash Items	-16,380	-8,987	-6,569	-2,944	-24,748
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-7,796	-29,820	36,675	-40,487	-13,712
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	36,828	13,086	87,415	10,851	38,595
Capital Expenditures	-16,988	-25,465	-15,328	-20,128	-28,525
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	19,292	4,926	1,111	-4,789	19,804
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	2,304	-20,539	-14,217	-24,917	-8,721
Financing Cash Flow Items	-1	-1	—	1,631	-1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-29,151	-12,918	-19,698	-23,534	-14,047
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	10,048	-20,332	53,539	-37,503	15,870